SBC Medical Group Holdings Incorporated Deferred Income Tax Expense (Benefit)
SBC Medical Group Holdings Incorporated (SBC) reported Deferred Income Tax Expense (Benefit) of -$3.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated deferred income tax expense (benefit) for the quarter ending 2026-06-30 was -$3.46M, a 892.08% decline year-over-year.
- SBC Medical Group Holdings Incorporated deferred income tax expense (benefit) for the quarter ending 2026-03-31 was -$1.09M, a 115.49% decline year-over-year.
- SBC Medical Group Holdings Incorporated deferred income tax expense (benefit) for the quarter ending 2025-12-31 was -$3.78M.
- SBC Medical Group Holdings Incorporated deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $1.65M, a 41.39% increase year-over-year.
- SBC Medical Group Holdings Incorporated deferred income tax expense (benefit) for fiscal 2025 was $5.33M.
- SBC Medical Group Holdings Incorporated deferred income tax expense (benefit) for fiscal 2024 was -$14.42M, a 450.49% decline from fiscal 2023.
- SBC Medical Group Holdings Incorporated deferred income tax expense (benefit) for fiscal 2023 was $4.11M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.46M 10-Q · filed 2026-08-13 | -$4.55M 10-Q · filed 2026-08-13 | -$8.32M derived: sum of 3 quarters · filed 2026-08-13 | -$6.67M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$1.09M 10-Q · filed 2026-05-14 | -$4.86M derived: sum of 2 quarters · filed 2026-05-14 | -$3.21M derived: sum of 3 quarters · filed 2026-05-14 | -$2.78M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$2.13M derived: sum of 2 quarters · filed 2026-03-27 | -$1.69M derived: sum of 3 quarters · filed 2026-08-13 | $5.33M 10-K · filed 2026-03-27 |
| 2025-09-30 | $1.65M 10-Q · filed 2025-11-14 | $2.09M derived: sum of 2 quarters · filed 2026-08-13 | $9.10M 10-Q · filed 2025-11-14 | -$3.16M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $436.76K 10-Q · filed 2026-08-13 | $7.45M 10-Q · filed 2026-08-13 | -$4.81M derived: sum of 3 quarters · filed 2026-08-13 | -$3.64M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $7.02M 10-Q · filed 2026-05-14 | -$5.25M derived: sum of 2 quarters · filed 2026-05-14 | -$4.08M derived: sum of 3 quarters · filed 2026-05-14 | -$7.04M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$12.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$11.09M derived: sum of 2 quarters · filed 2026-03-27 | -$14.06M derived: sum of 3 quarters · filed 2026-03-27 | -$14.42M 10-K · filed 2026-03-27 |
| 2024-09-30 | $1.17M 10-Q · filed 2025-11-14 | -$1.79M derived: sum of 2 quarters · filed 2025-11-14 | -$2.15M 10-Q · filed 2025-11-14 | $3.34M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$2.96M 10-Q · filed 2025-08-13 | -$3.32M 10-Q · filed 2025-08-13 | $2.17M derived: sum of 3 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$360.58K 10-Q · filed 2025-05-15 | $5.13M derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $5.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $4.11M 10-K · filed 2025-03-28 | ||
| 2023-09-30 | -$1.38M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |